Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) released its earnings results on Tuesday. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.02), Zacks reports. Bayer Aktiengesellschaft had a negative net margin of 3.80% and a positive return on equity of 16.77%.

Bayer Aktiengesellschaft Stock Performance

Bayer Aktiengesellschaft stock opened at $13.95 on Tuesday. Bayer Aktiengesellschaft has a 12-month low of $7.48 and a 12-month high of $15.23. The company has a market capitalization of $54.82 billion, a price-to-earnings ratio of -27.35, a price-to-earnings-growth ratio of 1.94 and a beta of 0.57. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.04 and a quick ratio of 0.67. The firm’s fifty day moving average price is $13.43 and its 200 day moving average price is $12.55.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a report on Friday, July 10th. Two research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy”.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft is a Germany-based life sciences company headquartered in Leverkusen. Founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott, the company develops products in health care and agriculture and serves customers in markets around the world.

Bayer operates through three primary businesses: Pharmaceuticals, Consumer Health and Crop Science. Its Pharmaceuticals segment develops prescription medicines in areas such as cardiovascular disease, women’s health, oncology, hematology and specialty therapies.